ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Down More Than 45%: 2 Buy-Rated Stocks Snatch Up Now

Concerns over high inflation, the Fed's hawkish monetary policy, and the potential for the economy to slide into a recession have caused the market to suffer a significant correction of late. But the current downtrend could be a great opportunity to scoop up shares of quality companies LiveRamp Holdings (RAMP) and Herbalife Nutrition (HLF), which are down more than 45% in price. These stocks are rated Buy in our proprietary rating system.

The major stock market indexes have suffered a massive correction lately, with S&P 500 down more than 20% from its peak in January. Geopolitical uncertainties, rising oil prices, worsening supply chain disruptions, and the Fed's intention to combat surging inflation by raising interest rates several times this year have rattled the stock market.

Furthermore, the increasing odds of the U.S. economy slipping into a recession have also perplexed investors. Last week, Wells Fargo CEO and president Charlie Scharf said it would be difficult for the U.S. to avoid "some kind of recession."

So, amid current market uncertainty, we think it could be wise to scoop the shares of fundamentally sound companies LiveRamp Holdings, Inc. (RAMP) and Herbalife Nutrition Ltd. (HLF), which are down more than 45% year-to-date. These stocks could rebound in the coming months based on their solid growth attributes. They are rated Buy in our proprietary POWR Ratings System.

LiveRamp Holdings, Inc. (RAMP)

Headquartered in San Francisco, RAMP, a technology company, offers enterprise data connectivity platform solutions in the United States, Europe, and Asia-Pacific. The company offers RampID, a true people-based identifier.

In February, RAMP announced that Adobe Advertising Cloud now supports RampID™ across channels, including desktop display, desktop video, mobile web, mobile in-app, connected TV (CTV), native, and audio. Advertisers can unlock people-based audience targeting, frequency capping, first- and third-party data activation, delivery reporting, supply-side integrations, exposure logs, and measurement support through Adobe's Advertising Solutions Group (ASG).

For the fourth quarter, ending March 31, 2022, RAMP's revenues increased 18.9% year-over-year to $141.73 million. Its gross profit improved 25.3% from its year-ago value to $102.25 million, while its non-GAAP operating income amounted to $1.00 million. The company's cash and cash equivalent increased 4.8% year-over-year to $600.16 for its fiscal year ending March 31, 2022.

Analysts expect RAMP's revenue to increase 16.9% year-over-year to $139.15 million for the first quarter, ending June 30, 2022. The $0.24 consensus EPS estimate for the same period, represents a 72.3% improvement year-over-year. The stock has plunged 46.9% in price year-to-date.

RAMP's POWR Ratings reflect this promising outlook. The company has an overall B rating , which translates to Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 distinct factors, each with its own weighting.

The stock also has a B grade for Value and Growth. Within the C-rated Technology - Services Industry, it is ranked #20 of 81 stocks.

To see additional POWR Ratings for Quality, Sentiment, Stability, and Momentum for RAMP, click here.

Herbalife Nutrition Ltd. (HLF)

HLF provides nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company offers products in weight management, targeted nutrition, energy, sports and fitness, and outer nutrition. The company is headquartered in Los Angeles, California.

In the first quarter, ending March 31, 2022, HLF's worldwide net sales amounted to $1.34 billion. Its operating income came in at $153.10 million, while its adjusted net income was  $101.00 million. The company's adjusted EPS stood at $0.99.

The  $0.98 consensus EPS estimate for the fourth quarter ending Dec. 31, 2022, represents a 71.4% improvement year-over-year. Analysts expect HLF's revenue to increase 1.1% year-over-year to $1.33 billion for the same period. In addition, the company has an impressive earnings surprise history; it surpassed the consensus EPS estimates in three of the trailing four quarters. The stock has declined 48.6% year-to-date.

HLF's strong fundamentals are reflected in its POWR Ratings. The stock has an overall B rating, which equates to Buy in our POWR Ratings system. HLF  also has an A grade for Quality and Value. Within the A-rated Medical - Consumer Goods industry, it is ranked #3 of 8 stocks.

In total, we rate HLF on eight distinct levels. Beyond what we have stated above, we have also given HLF grades for Stability, Sentiment, Growth, and Momentum. Get all the HLF ratings here.

Want More Great Investing Ideas?

3 Stocks to DOUBLE This Year

Top 10 Stocks for 2022

Bear Market Scare? Read Before Your Next Trade

7 SEVERELY Undervalued Stocks


RAMP shares were trading at $26.32 per share on Thursday afternoon, up $0.87 (+3.42%). Year-to-date, RAMP has declined -45.11%, versus a -14.24% rise in the benchmark S&P 500 index during the same period.



About the Author: Spandan Khandelwal

Spandan's is a financial journalist and investment analyst focused on the stock market. With her ability to interpret financial data, she aims to help investors evaluate the fundamentals of a company before investing.

More...

The post Down More Than 45%: 2 Buy-Rated Stocks Snatch Up Now appeared first on StockNews.com
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.